Stockreport

U.S. IPO Weekly Recap: One Biotech Prices Ahead Of The IPO Market's Quarantine [Seeking Alpha]

DFP Healthcare Acquisitions Corp. - Unit  (DFPHU) 
PDF Summary One biotech pulled off an this week, along with a blank check company. Imara, a Phase 2 biotech targeting sickle cell disease, priced an upsized at the low end [Read more]